19-57779090-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017652.4(ZNF586):c.503G>A(p.Arg168His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000404 in 1,461,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017652.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF586 | NM_017652.4 | c.503G>A | p.Arg168His | missense_variant | 3/3 | ENST00000396154.7 | NP_060122.2 | |
ZNF586 | NM_001204814.2 | c.374G>A | p.Arg125His | missense_variant | 4/4 | NP_001191743.1 | ||
ZNF586 | NM_001077426.3 | c.376G>A | p.Val126Ile | missense_variant | 2/2 | NP_001070894.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF586 | ENST00000396154.7 | c.503G>A | p.Arg168His | missense_variant | 3/3 | 1 | NM_017652.4 | ENSP00000379458.1 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 150832Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250236Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135708
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461846Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727238
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000331 AC: 5AN: 150950Hom.: 0 Cov.: 32 AF XY: 0.0000407 AC XY: 3AN XY: 73798
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 11, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at